Option chain shows key data for Biora Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Biora Therapeutics.

Biora Therapeutics (OTC:BIOR) Stock, Option Chain

Biora Therapeutics

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

News

BIOR

Biora Therapeutics shares are trading lower by 45% during Tuesday&#39;s session. The company announced that it will be delisted from Nasdaq.

Why Biora Therapeutics (BIOR) Stock Is Down 45%

wall street ai16

Earnings

Equities

Eurozone

Commodities

Markets

Trading Ideas

CMRX

CPIX

CRVO

ORCL

QURE

Dow Falls 150 Points; Oracle Posts Downbeat Results

Movers

Intraday Update

AKAN

AKTS

ASTI

ATGL

BNED

BSFC

BTTR

CADL

DAVA

DECK

GNLX

GYRE

HLTH

IMCR

INTU

ISSC

KRON

LILM

LUCY

LUXH

MGNI

MRNO

MRUS

NCPL

NTES

OKLO

ONMD

PEGY

RDZN

ROST

SMFL

SMMT

SNSE

SVMH

SWIN

TLSI

VSTM

WDAY

WORX

XCUR

ZCAR

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Biora Therapeutics Inc

BIORA THERAPEUTCS INC by Biora Therapeutics, Inc.

BioRegenx Inc

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies Inc

Biorem Inc

Press Releases

Biora Therapeutics Announces Positive Nasdaq Listing Decision

Biora Therapeutics Achieves ISO 13485 Certification

Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024

Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

Health Care

Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

Financing

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

HC Wainwright & Co.

Comments

Biora Therapeutics

Biora Therapeutics (BIOR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga